loading...| Preferred Name |
edoxaban tosylate |
|
| Synonyms |
DU-176b |
|
| Definitions |
The tosylate salt form of edoxaban, an orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes renal excretion. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C96542" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96542" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000758684 |
|
| altLabel |
DU-176b N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N- dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2- carboxamido)cyclohexyl)oxamide, 4- methylbenzenesulfonate |
|
| cui |
C3272851 C2607549 |
|
| DATE FIRST PUBLISHED |
2014-03-06 |
|
| Date last modified |
2014-03-06 |
|
| definition |
The tosylate salt form of edoxaban, an orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes renal excretion. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C96542" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96542" NCI Thesaurus) |
|
| NCI ID |
C96542 |
|
| notation |
CDR0000758684 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
edoxaban tosylate |
|
| tui |
T109 T121 |